P

Inventor

DOW ROBERT L

US53 patents
⚠️ This page may combine multiple inventors who share the name “DOW ROBERT L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PFIZER

34 patents
US6194454B1Feb 27, 2001

Cyano containing oxamic acids and derivatives as thyroid receptor ligands

PFIZER147 citations98
US5639757AJun 17, 1997

4-aminopyrrolo[2,3-d]pyrimidines as tyrosine kinase inhibitors

PFIZER119 citations98
US5593997AJan 14, 1997

4-aminopyrazolo(3-,4-D)pyrimidine and 4-aminopyrazolo-(3,4-D)pyridine tyrosine kinase inhibitors

PFIZER355 citations98
US6787652B1Sep 7, 2004

6-Azauracil derivatives as thyroid receptor ligands

PFIZER55 citations96
US6380223B1Apr 30, 2002

Glucocorticoid receptor modulators

PFIZER78 citations95
US5859044AJan 12, 1999

β-adrenergic agonists

PFIZER84 citations95
US6194439B1Feb 27, 2001

Tricyclic polyhydroxylic tyrosine kinase inhibitors

PFIZER40 citations93
US5977124ANov 2, 1999

β-adrenergic agonists

PFIZER27 citations93
US5627200AMay 6, 1997

β3 -Adrenoceptor agonists and antagonists for the treatment of intestinal motility disorders, depression, prostate disease and dyslipidemia

PFIZER57 citations93
US7230024B2Jun 12, 2007

Cannabinoid receptor ligands and uses thereof

PFIZER32 citations92
US7145012B2Dec 5, 2006

Cannabinoid receptor ligands and uses thereof

PFIZER15 citations92
US6699893B2Mar 2, 2004

Glucocorticoid receptor modulators

PFIZER20 citations92
US5498621AMar 12, 1996

Oxazolidinedione hypoglycemic agents

PFIZER30 citations92
US5767133AJun 16, 1998

Secondary amines as antidiabetic and antiobesity agents

PFIZER24 citations91
US6545018B2Apr 8, 2003

Oxamic acids and derivatives as thyroid receptor ligands

PFIZER26 citations89
US6326398B1Dec 4, 2001

Oxamic acids and derivatives as thyroid receptor ligands

PFIZER33 citations89
US6657063B1Dec 2, 2003

Combinations of β3 agonists and growth hormone secretagogues

PFIZER13 citations84
US6001856ADec 14, 1999

β-adrenergic agonists to reduce a wasting condition

PFIZER17 citations84
US7166593B2Jan 23, 2007

Glucocorticoid receptor modulators

PFIZER11 citations83
US6291489B1Sep 18, 2001

Process for substituted pyridines

PFIZER18 citations82
US5326905AJul 5, 1994

Benzylphosphonic acid tyrosine kinase inhibitors

PFIZER18 citations82
US5908930AJun 1, 1999

5,10-dihydropyrimdo 4,5-b!quinolin-4(1H)-one tyrosine kinase inhibitors

PFIZER15 citations74
US5843972ADec 1, 1998

Heterocyclic β-adrenergic agonists

PFIZER16 citations72
US6040310AMar 21, 2000

4-aminopyrrole (3,2-d) pyrimidines as neuropeptide Y receptor antagonists

PFIZER8 citations66
US7718645B2May 18, 2010

Substituted bicyclolactam compounds

PFIZER2 citations63
US7241788B2Jul 10, 2007

Cannabinoid receptor ligands and uses thereof

PFIZER3 citations63
US7151097B2Dec 19, 2006

Bicyclic pyrazolyl and imidazolyl compounds and uses thereof

PFIZER5 citations63
US5457237AOct 10, 1995

Dihydroxyindanone tyrosine kinase inhibitors

PFIZER6 citations63
US6930107B2Aug 16, 2005

6-azauracil derivatives as thyroid receptor ligands

PFIZER2 citations62
US9399626B2Jul 26, 2016

2-thiopyrimidinones

PFIZER2 citations59
US9181252B2Nov 10, 2015

N1/N2-lactam acetyl-CoA carboxylase inhibitors

PFIZER0 citations52
US8993586B2Mar 31, 2015

N1/N2-lactam acetyl-CoA carboxylase inhibitors

PFIZER0 citations52
US9873673B2Jan 23, 2018

2-thiopyrimidinones

PFIZER0 citations48
US6844441B2Jan 18, 2005

Process for preparing substituted pyridines

PFIZER0 citations47

DOW ROBERT L

6 patents

US NAVY

4 patents

PROCTOR PAUL W

2 patents

(unassigned)

1 patent

US ARMY

1 patent

PFIZER PROD INC

1 patent

GRIFFITH DAVID A

1 patent

Showing the top 50 of 53 patents by PatentIndex Score.